DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Supriya Lifescience
03 1Naprod Life Sciences
04 2AFT Pharmaceuticals
05 1Accord healthcare
06 1Apotex Inc
07 1Aspiro Pharma
08 1Aurobindo Pharma Limited
09 1Baxter Healthcare Corporation
10 2Biological E
11 1Chia Tai Tianqing Pharmaceutical Group
12 1Etico Lifesciences
13 1Fresenius Kabi USA
14 1GENEYORK PHARMS
15 1Grupo Azevedos
16 1Lupin Ltd
17 1MERCK CANADA INC
18 2MSD INTL GMBH
19 1MSD(Pty) Ltd
20 1MSN Laboratories
21 2Medsurge Healthcare
22 7Merck & Co
23 1Navinta
24 1Piramal Enterprises Limited
25 1Polifarma
26 1Praxgen
27 1Qilu Pharmaceutical
28 2Reach Pharmaceuticals
29 1Sagent Pharmaceuticals
30 1Sakar Healthcare
31 1Sandoz B2B
32 1Steriscience
33 1Tecnimede
34 1Teva Pharmaceutical Industries
35 1TherDose Pharma
36 2Viatris
01 1Caps
02 1Dry Sub
03 1Fosaprepitant 150Mg 10 Ml 1 Units Parenteral Use
04 1INJ
05 3Injection
06 1Lyophilised Injection
07 1Lyophilized Injection
08 1POWDER FOR SOLUTION
09 2POWDER FOR SOLUTION FOR INFUSION
10 22POWDER;INTRAVENOUS
11 1Powder for Solution for Injection
12 1Powder for solution for Infusion
13 1Powder for solution for infusion
14 1SOLUTION;INTRAVENOUS
15 1UNKNOWN
16 1Vial
17 8Blank
01 8DISCN
02 1Originator
03 15RX
04 24Blank
01 2EMEND
02 1EMEND IV
03 1Emend
04 2Emend IV
05 1FOCINVEZ
06 21FOSAPREPITANT DIMEGLUMINE
07 2FOSAPREPITANT MEDSURGE
08 2FOSAPREPITANT MSN
09 2FOSAPREPITANT-AFT
10 2IVEMEND
11 1IVEMEND 150 mg
12 2Ivemend
13 9Blank
01 8Australia
02 1Canada
03 6India
04 1Italy
05 2Portugal
06 1South Africa
07 2Sweden
08 2Switzerland
09 1Turkey
10 24USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-09
Application Number : 211160
Regulatory Info : RX
Registration Country : USA
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Naprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilised Injection
Dosage Strength : 150MG/Vial
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-26
Application Number : 204025
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 205020
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-07-29
Application Number : 214616
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-01-12
Application Number : 210625
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211860
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 212309
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-03-03
Application Number : 212143
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Lyophilized Injection
Dosage Strength : 150MG/ML
Packaging : Single dose glass vial
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2016-06-09
Application Number : 206197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210689
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-01-25
Application Number : 22023
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : EMEND
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2010-11-12
Application Number : 22023
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : IVEMEND
Dosage Form : POWDER FOR SOLUTION FOR INFUSION
Dosage Strength : 150 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : IVEMEND
Dosage Form : POWDER FOR SOLUTION FOR INFUSION
Dosage Strength : 115 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Ivemend
Dosage Form : Fosaprepitant 150Mg 10 Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 10 ml 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 209965
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-08-20
Application Number : 212957
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2023-05-16
Application Number : 214683
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2021-10-04
Application Number : 213199
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-09-08
Application Number : 213106
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : UNKNOWN
Dosage Strength : UNKNOWN
Packaging :
Approval Date :
Application Number : 204845
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2020-12-08
Application Number : 203939
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOCINVEZ
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/50ML (EQ 3MG BASE/ML)
Packaging :
Approval Date : 2023-08-22
Application Number : 216686
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 210064
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 115MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 204015
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FOSAPREPITANT DIMEGLUMINE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : EQ 150MG BASE/VIAL
Packaging :
Approval Date : 2019-09-05
Application Number : 211624
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
